Statins for Treating Brain Bleeding
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if the statin drug atorvastatin can help people recover from a type of stroke called a brain bleed. It is for adults who have a moderate-sized bleed in the upper part of the brain and can start taking the drug within 48 hours of symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a brain bleed (intracerebral hemorrhage) seen on a CT scan.
- You are between 18 and 80 years old.
- The bleed is in the upper part of your brain (not the lower part or brainstem).
- Your symptoms started between 3 and 24 hours ago, and you can start the study drug within 48 hours.
- You are conscious enough to have a Glasgow Coma Scale score of 9 or higher.
- Your bleed is between 5 and 35 milliliters in size (about the size of a small egg to a large walnut).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.
This trial tests whether high-dose atorvastatin can help protect the artery wall after emergency clot-removal treatment for an acute stroke. It uses a special 3T MRI scan to look for changes in the blood vessels and may lower the risk of future problems if the artery wall is better protected.
This study looks at whether high-dose atorvastatin (a cholesterol medicine) can lower the risk of bleeding-related complications in some people after an ischemic stroke. You may be eligible if your brain scan shows tiny “microbleeds,” which can raise bleeding risk.
This trial studies whether continuing or stopping statin medicine after a spontaneous bleeding stroke in the brain (called lobar ICH) leads to better outcomes. It may help clarify if statins are safer to stay on—or better to pause—after this type of event.
This trial tests whether giving a statin medication very early (within 6 hours of symptoms) can improve recovery after a brain aneurysm bleed. It aims to see if early treatment helps protect the brain.
This trial tests whether a higher-dose statin can help after an ischemic stroke in people who have specific plaque patterns in brain blood vessels. It may help lower the risk of another stroke by targeting the artery plaque process.
Hear when a new Cerebrovascular Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.